Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Cancers|July 14, 2023
Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic FactorsEleonora Boscaro, Irene Urbino, Federica Maria Catania, et al.Cancers|October 23, 2021
Evolving Therapeutic Approaches for Older Patients with Acute Myeloid Leukemia in 2021Irene Urbino, Carolina Secreto, Matteo Olivi, et al.European Journal of Haematology|March 15, 2023
Validation of National Early Warning Score and Quick Sequential (sepsis-related) Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapyChiara Frairia, Barbara Nicolino, Carolina Secreto, et al.Mediterranean Journal of Hematology and Infectious Diseases|March 13, 2023
Levofloxacin Prophylaxis Versus no Prophylaxis in Acute Myeloid Leukemia During Post-Induction Aplasia: a Single Center StudyIrene Urbino, Chiara Frairia, Alessandro Busca, et al.Expert Review of Hematology|May 21, 2026
T-cell acute lymphoblastic leukemia in adults: current treatment approaches and future perspectivesLorenzo Celona, Eleonora Boscaro, Giulia Berutto, et al.Haematologica|November 26, 2016
Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutationsChristian Scharenberg, Valentina Giai, Andrea Pellagatti, et al.Annals of Hematology|February 7, 2022
Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational studyFederica Martella, Marco Cerrano, Daniela Di Cuonzo, et al.International Journal of Emergency Medicine|September 5, 2024
Decrease of haemoconcentration reliably detects hydrostatic pulmonary oedema in dyspnoeic patients in the emergency department - a machine learning approachFrancesco Gavelli, Luigi Mario Castello, Xavier Monnet, et al.Frontiers in Pharmacology|June 12, 2023
Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26+ leukemia stem cellsPaola Pacelli, Adele Santoni, Anna Sicuranza, et al.Leukemia|October 17, 2012
The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblastsMaryam Nikpour, Christian Scharenberg, Anquan Liu, et al.Pageof 5